Published in Obesity and Diabetes Week, June 26th, 2006
The results of this study appear in a recent issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD) and recommend that weight loss, medications to decrease insulin resistance and extending duration or dosage of therapy are strategies that may improve the efficacy of therapy.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.